How 2017 Compares to the Steroid Era: Part I

The 2017 season has seen offensive levels rise to a height unmatched in major-league baseball for quite some time. Overall this year, teams are averaging 4.65 runs per game, the highest mark since 2007 — though not quite the five runs per game teams averaged in 1999 and 2000. Most of the offensive increase can be traced to a juiced ball. There’s also been a lot of talk about the role of a fly-ball revolution of some sort or another in the establishment of a new league-wide seasonal home-run record.
An increase in PED use has now been raised as an issue, as well. MLB has administered both PED testing and PED-related suspensions since 2004; both have existed in the minors since 2001. Even with those measures in place, however, power continues to be associated with steroid use, and unfounded rumors have hounded the authors of every breakout season over the last decade. With the rise of power in recent years, the whole league is under suspicion. But how similar is this version of the league to the one now known as the “steroid era”? Let’s take a look at what the latter actually looked like and how it compares to now.
Our split tools are very expansive going back to 2002. This is convenient because 2002 was the last season that lacked PED testing of any kind. It might not have been quite the height of that period now regarded as the “steroid era” — that was probably 1999 and 2000 — but the league looked quite different before testing and suspensions were permitted.

